114 related articles for article (PubMed ID: 21908217)
1. A comparative QSAR on 1,2,5-thiadiazolidin-3-one 1,1-dioxide compounds as selective inhibitors of human serine proteinases.
García J; Duchowicz PR; Rozas MF; Caram JA; Mirífico MV; Fernández FM; Castro EA
J Mol Graph Model; 2011 Nov; 31():10-9. PubMed ID: 21908217
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of serine proteases by functionalized sulfonamides coupled to the 1,2,5-thiadiazolidin-3-one 1,1 dioxide scaffold.
Groutas WC; He S; Kuang R; Ruan S; Tu J; Chan HK
Bioorg Med Chem; 2001 Jun; 9(6):1543-8. PubMed ID: 11408173
[TBL] [Abstract][Full Text] [Related]
3. X-ray snapshot of the mechanism of inactivation of human neutrophil elastase by 1,2,5-thiadiazolidin-3-one 1,1-dioxide derivatives.
Huang W; Yamamoto Y; Li Y; Dou D; Alliston KR; Hanzlik RP; Williams TD; Groutas WC
J Med Chem; 2008 Apr; 51(7):2003-8. PubMed ID: 18318470
[TBL] [Abstract][Full Text] [Related]
4. Potent inhibition of human leukocyte elastase by 1,2,5-thiadiazolidin-3-one 1,1 dioxide-based sulfonamide derivatives.
Lai Z; Gan X; Wei L; Alliston KR; Yu H; Li YH; Groutas WC
Arch Biochem Biophys; 2004 Sep; 429(2):191-7. PubMed ID: 15313222
[TBL] [Abstract][Full Text] [Related]
5. 1,2,5-Thiadiazolidin-3-one 1,1 dioxide: a powerful scaffold for probing the S' subsites of (chymo)trypsin-like serine proteases.
Groutas WC; Epp JB; Kuang R; Ruan S; Chong LS; Venkataraman R; Tu J; He S; Yu H; Fu Q; Li YH; Truong TM; Vu NT
Arch Biochem Biophys; 2001 Jan; 385(1):162-9. PubMed ID: 11361013
[TBL] [Abstract][Full Text] [Related]
6. QSAR studies on aminothiazole derivatives as aurora a kinase inhibitors.
Qin J; Xi L; Du J; Liu H; Yao X
Chem Biol Drug Des; 2010 Dec; 76(6):527-37. PubMed ID: 21040493
[TBL] [Abstract][Full Text] [Related]
7. Utilization of the 1,2,5-thiadiazolidin-3-one 1,1 dioxide scaffold in the design of potent inhibitors of serine proteases: SAR studies using carboxylates.
Kuang R; Epp JB; Ruan S; Chong LS; Venkataraman R; Tu J; He S; Truong TM; Groutas WC
Bioorg Med Chem; 2000 May; 8(5):1005-16. PubMed ID: 10882012
[TBL] [Abstract][Full Text] [Related]
8. 1,2,5-Thiadiazolidin-3-one 1,1-dioxide-based heterocyclic sulfides are potent inhibitors of human tryptase.
Wong T; Groutas CS; Mohan S; Lai Z; Alliston KR; Vu N; Schechter NM; Groutas WC
Arch Biochem Biophys; 2005 Apr; 436(1):1-7. PubMed ID: 15752703
[TBL] [Abstract][Full Text] [Related]
9. 1,2-Benzisothiazol-3-one 1,1-dioxide inhibitors of human mast cell tryptase.
Combrink KD; Gülgeze HB; Meanwell NA; Pearce BC; Zulan P; Bisacchi GS; Roberts DG; Stanley P; Seiler SM
J Med Chem; 1998 Nov; 41(24):4854-60. PubMed ID: 9822554
[TBL] [Abstract][Full Text] [Related]
10. Structure-based design of a general class of mechanism-based inhibitors of the serine proteinases employing a novel amino acid-derived heterocyclic scaffold.
Groutas WC; Kuang R; Venkataraman R; Epp JB; Ruan S; Prakash O
Biochemistry; 1997 Apr; 36(16):4739-50. PubMed ID: 9125494
[TBL] [Abstract][Full Text] [Related]
11. Validated quantitative structure-activity relationship analysis of a series of 2-aminothiazole based p56(Lck) inhibitors.
Li J; Du J; Xi L; Liu H; Yao X; Liu M
Anal Chim Acta; 2009 Jan; 631(1):29-39. PubMed ID: 19046675
[TBL] [Abstract][Full Text] [Related]
12. Dimethylthiazolidine carboxylic acid as a rigid p3 unit in inhibitors of serine proteases: application to two targets.
Kawai SH; Aubry N; Duceppe JS; Llinàs-Brunet M; LaPlante SR
Chem Biol Drug Des; 2009 Nov; 74(5):517-22. PubMed ID: 19780760
[TBL] [Abstract][Full Text] [Related]
13. An integrated approach to ligand- and structure-based drug design: development and application to a series of serine protease inhibitors.
Nicolotti O; Miscioscia TF; Carotti A; Leonetti F; Carotti A
J Chem Inf Model; 2008 Jun; 48(6):1211-26. PubMed ID: 18540590
[TBL] [Abstract][Full Text] [Related]
14. 3D-QSAR CoMFA studies on trypsin-like serine protease inhibitors: a comparative selectivity analysis.
Bhongade BA; Gouripur VV; Gadad AK
Bioorg Med Chem; 2005 Apr; 13(8):2773-82. PubMed ID: 15781388
[TBL] [Abstract][Full Text] [Related]
15. Profiling the structural determinants for the selectivity of representative factor-Xa and thrombin inhibitors using combined ligand-based and structure-based approaches.
Bhunia SS; Roy KK; Saxena AK
J Chem Inf Model; 2011 Aug; 51(8):1966-85. PubMed ID: 21761917
[TBL] [Abstract][Full Text] [Related]
16. Potent inhibition of serine proteases by heterocyclic sulfide derivatives of 1,2,5-thiadiazolidin-3-one 1,1 dioxide.
He S; Kuang R; Venkataraman R; Tu J; Truong TM; Chan HK; Groutas WC
Bioorg Med Chem; 2000 Jul; 8(7):1713-7. PubMed ID: 10976518
[TBL] [Abstract][Full Text] [Related]
17. Structural and mechanistic insight into how antibodies inhibit serine proteases.
Ganesan R; Eigenbrot C; Kirchhofer D
Biochem J; 2010 Sep; 430(2):179-89. PubMed ID: 20704569
[TBL] [Abstract][Full Text] [Related]
18. Alkyne derivatives of isocoumarins as clickable activity-based probes for serine proteases.
Haedke U; Götz M; Baer P; Verhelst SH
Bioorg Med Chem; 2012 Jan; 20(2):633-40. PubMed ID: 21454080
[TBL] [Abstract][Full Text] [Related]
19. Ahp cyclodepsipeptides: the impact of the Ahp residue on the "canonical inhibition" of S1 serine proteases.
Stolze SC; Meltzer M; Ehrmann M; Kaiser M
Chembiochem; 2013 Jul; 14(11):1301-8. PubMed ID: 23794257
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, semipreparative HPLC separation, biological evaluation, and 3D-QSAR of hydrazothiazole derivatives as human monoamine oxidase B inhibitors.
Chimenti F; Secci D; Bolasco A; Chimenti P; Granese A; Carradori S; Maccioni E; Cardia MC; Yáñez M; Orallo F; Alcaro S; Ortuso F; Cirilli R; Ferretti R; Distinto S; Kirchmair J; Langer T
Bioorg Med Chem; 2010 Jul; 18(14):5063-70. PubMed ID: 20579890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
